Skip to content
10-Q

Quarterly Report

NRX Pharmaceuticals, Inc. NRXP

0001437749-25-035210

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 13, 2025 28.1M sh
Operating Cash Flow Q3 2024 · Sep 30, 2025 −$10.4M
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$8.54M
Cash And Equivalents Q3 2024 · Sep 30, 2025 $7.18M
Cash And Equivalents Q3 2024 · Dec 31, 2024 $1.44M
Stockholders Equity Q3 2024 · Sep 30, 2025 −$25.76M
Stockholders Equity Q3 2024 · Jun 30, 2025 −$35.62M
Stockholders Equity Q3 2024 · Mar 31, 2025 −$25.16M
Stockholders Equity Q3 2024 · Dec 31, 2024 −$23.22M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$18.82M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$18.39M
Stockholders Equity Q3 2024 · Mar 31, 2024 −$15.07M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$11.73M
Current Liabilities Q3 2024 · Sep 30, 2025 $40.59M
Current Liabilities Q3 2024 · Dec 31, 2024 $21.86M
Total Liabilities Q3 2024 · Sep 30, 2025 $40.75M
Total Liabilities Q3 2024 · Dec 31, 2024 $26.87M
Current Assets Q3 2024 · Sep 30, 2025 $11.95M
Current Assets Q3 2024 · Dec 31, 2024 $3.3M
Total Assets Q3 2024 · Sep 30, 2025 $15M
Total Assets Q3 2024 · Dec 31, 2024 $3.65M
Eps Basic Q3 2024 · Sep 30, 2025 −$0.27
Eps Basic Q3 2024 · Sep 30, 2025 −$1.54
Eps Basic Q3 2024 · Sep 30, 2024 −$0.15
Eps Basic Q3 2024 · Sep 30, 2024 −$1.59
Sga Expense Q3 2024 · Sep 30, 2025 $2.81M
Sga Expense Q3 2024 · Sep 30, 2025 $8.49M
Sga Expense Q3 2024 · Sep 30, 2024 $2.41M
Sga Expense Q3 2024 · Sep 30, 2024 $10.9M
Rd Expense Q3 2024 · Sep 30, 2025 $1.43M
Rd Expense Q3 2024 · Sep 30, 2025 $3.22M
Rd Expense Q3 2024 · Sep 30, 2024 $611K
Rd Expense Q3 2024 · Sep 30, 2024 $5.16M
Net Income Q3 2024 · Sep 30, 2025 −$5.89M
Net Income Q3 2024 · Sep 30, 2025 −$28.98M
Net Income Q3 2024 · Jun 30, 2025 −$17.58M
Net Income Q3 2024 · Mar 31, 2025 −$5.51M
Net Income Q3 2024 · Sep 30, 2024 −$1.62M
Net Income Q3 2024 · Sep 30, 2024 −$16.05M
Net Income Q3 2024 · Jun 30, 2024 −$7.9M
Net Income Q3 2024 · Mar 31, 2024 −$6.53M
Operating Income Q3 2024 · Sep 30, 2025 −$4.02M
Operating Income Q3 2024 · Sep 30, 2025 −$11.6M
Operating Income Q3 2024 · Sep 30, 2024 −$3.02M
Operating Income Q3 2024 · Sep 30, 2024 −$16.07M
Cost Of Revenue Q3 2024 · Sep 30, 2025 $97K
Cost Of Revenue Q3 2024 · Sep 30, 2025 $97K
Cost Of Revenue Q3 2024 · Sep 30, 2024 $0
Cost Of Revenue Q3 2024 · Sep 30, 2024 $0
Revenue Q3 2024 · Sep 30, 2025 $242K
Revenue Q3 2024 · Sep 30, 2025 $242K
Revenue Q3 2024 · Sep 30, 2024 $0
Revenue Q3 2024 · Sep 30, 2024 $0